Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial

被引:0
|
作者
Maria Cristina Mondardini
Francesca Sperotto
Marco Daverio
Fabio Caramelli
Dario Gregori
Maria Francesca Caligiuri
Francesca Vitale
Maria Teresa Cecini
Marco Piastra
Aldo Mancino
Andrea Pettenazzo
Giorgio Conti
Angela Amigoni
机构
[1] University-Hospital S.Orsola-Malpighi Policlinic,Department of Woman, Child and Urological Diseases, Pediatric Intensive Care Unit
[2] University-Hospital of Padua,Department of Woman’s and Child’s Health, Pediatric Intensive Care Unit
[3] University-Hospital of Padua,Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health
[4] Catholic University of Rome,Department of Anesthesia and Intensive Care, Pediatric Intensive Care Unit and Pediatric Trauma Center
[5] A Gemelli Policlinic,undefined
来源
Trials | / 20卷
关键词
Dexmedetomidine; Analgesia; Sedation; Withdrawal syndrome; Abstinence syndrome; Pediatric intensive care unit;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial
    Mondardini, Maria Cristina
    Sperotto, Francesca
    Daverio, Marco
    Caramelli, Fabio
    Gregori, Dario
    Caligiuri, Maria Francesca
    Vitale, Francesca
    Cecini, Maria Teresa
    Piastra, Marco
    Mancino, Aldo
    Pettenazzo, Andrea
    Conti, Giorgio
    Amigoni, Angela
    [J]. TRIALS, 2019, 20 (01)
  • [2] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    [J]. ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
  • [3] Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
    Campillo, Jeremy T.
    Bikita, Paul
    Hemilembolo, Marlhand
    Louya, Frederic
    Missamou, Francois
    Pion, Sebastien D. S.
    Boussinesq, Michel
    Chesnais, CedricB
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 19 - 27
  • [4] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Ying Zhao
    Yuan-Yuan Yang
    Bao-Lin Yang
    Ya-Wei Du
    Da-Wei Ren
    Hong-Mei Zhou
    Jing Wang
    Hui-Min Yang
    Yao-Xian Wang
    Ying-Ying Zhang
    Sheng-Xian Wu
    [J]. Trials, 22
  • [5] Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
    Zhao, Ying
    Yang, Yuan-Yuan
    Yang, Bao-Lin
    Du, Ya-Wei
    Ren, Da-Wei
    Zhou, Hong-Mei
    Wang, Jing
    Yang, Hui-Min
    Wang, Yao-Xian
    Zhang, Ying-Ying
    Wu, Sheng-Xian
    [J]. TRIALS, 2021, 22 (01)
  • [6] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Chen, Qi
    Wang, Zi
    Lv, Jicheng
    Liu, Lijun
    Li, Hang
    Sun, Weiwei
    Huo, Yanhong
    Guo, Yingbo
    Shen, Cun
    Li, Shichao
    Chen, Zhenjie
    Zhou, Jingwei
    [J]. TRIALS, 2022, 23 (01)
  • [7] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Liang Dai
    Linda L. D. Zhong
    Yan Cao
    Wei Chen
    Ying Cheng
    Xiu-Fang Lin
    Zhao-Xiang Bian
    Ai-Ping Lu
    [J]. Trials, 17
  • [8] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Qi Chen
    Zi Wang
    Jicheng Lv
    Lijun Liu
    Hang Li
    Weiwei Sun
    Yanhong Huo
    Yingbo Guo
    Cun Shen
    Shichao Li
    Zhenjie Chen
    Jingwei Zhou
    [J]. Trials, 23
  • [9] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Dai, Liang
    Zhong, Linda L. D.
    Cao, Yan
    Chen, Wei
    Cheng, Ying
    Lin, Xiu-Fang
    Bian, Zhao-Xiang
    Lu, Ai-Ping
    [J]. TRIALS, 2016, 17
  • [10] Aripiprazole for prevention of delirium in the neurosurgical intensive care unit: a double-blind, randomized, placebo-controlled study
    Mokhtari, Majid
    Farasatinasab, Maryam
    Machian, Mina Jafarpour
    Yaseri, Mehdi
    Ghorbani, Mohammad
    Hashemi, Seyed Mahmood Ramak
    Nikoobakht, Mehdi
    Golchin, Navid
    Mohammadi, Gholamhasan
    Sistanizad, Mohammad
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (04) : 491 - 499